Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
Netherlands
/
Materials
/
Corbion
CRBN
Corbion
Rising Regulation And Costs Will Pressure Bioplastics With Fleeting Upsides
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 6 Analysts
Published
16 Jul 25
Updated
24 Jul 25
1
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
€14.00
17.0% overvalued
intrinsic discount
24 Jul
€16.38
Loading
1Y
-18.7%
7D
-8.0%
Author's Valuation
€14.0
17.0% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
€14.0
17.0% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
-15m
1b
2014
2017
2020
2023
2025
2026
2028
Revenue €1.3b
Earnings €98.0m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
1.72%
Chemicals revenue growth rate
0.46%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.29%
Calculation
€98.04m
Earnings '28
x
9.78x
PE Ratio '28
=
€958.60m
Market Cap '28
€958.60m
Market Cap '28
/
57.46m
No. shares '28
=
€16.68
Share Price '28
€16.68
Share Price '28
Discounted to 2025 @ 6.30% p.a.
=
€13.89
Fair Value '25
